Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
2
×
life sciences
national blog main
amgen
andrew berens
avapritinib
blueprint medicines
boston
boston top stories
cancer
cholesterol
data
deciphera pharmaceuticals
gastrointestinal stromal tumor
gist
gleevec
imatinib
inclisiran
ldl
mark timney
mt sinai hospital
national top stories
new york
new york blog main
new york top stories
pcsk9
peter wijngaard
praluent
prashant vaishnava
regeneron pharmaceuticals
regorafenib
repatha
ripretinib
san francisco blog main
san francisco top stories
sanofi
steve hoerter
stivarga
sunitinib
What
announced
2
×
drug
2
×
medicine
aces
approval
big
blueprint
cancer
ceo
chasing
cholesterol
deadly
deciphera
fda
filing
flexible
forms
gi
inclisiran
key
lowering
meant
medco
medicines
morning
nasdaq
open
passed
pharamceuticals
plans
pricing
seek
taken
test
treats
tumor
twice
type
week
year
Language
unset
2
×
Current search:
drug
×
unset
×
announced
×
" clinical trials "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
